FFA
LEGN icon

Farther Finance Advisors’s Legend Biotech LEGN Stock Holding History

Farther Finance Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.53K Sell
429
-369
-46% -$7.87K ﹤0.01% 4715
2026
Q2 		$23.2K Sell
798
-334
-30% -$9.01K ﹤0.01% 3868
2026
Q1 		$21.6K Buy
1,132
+191
+20% +$3.64K ﹤0.01% 3605
2025
Q4 		$20.5K Buy
941
+906
+2,589% +$26K ﹤0.01% 3426
2025
Q3 		$1.14K Sell
35
-34
-49% -$1.25K ﹤0.01% 4328
2025
Q2 		$2.45K Sell
69
-397
-85% -$12.9K ﹤0.01% 3635
2025
Q1 		$14.7K Buy
466
+444
+2,018% +$15.9K ﹤0.01% 2544
2024
Q4 		$716 Sell
22
-53
-71% -$2.19K ﹤0.01% 3353
2024
Q3 		$3.65K Buy
75
+18
+32% +$959 ﹤0.01% 2773
2024
Q2 		$2.62K Buy
57
+6
+12% +$277 ﹤0.01% 2682
2024
Q1 		$2.92K Buy
+51
New +$3.08K ﹤0.01% 2331

Other funds holding LEGN

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Farther Finance Advisors's LEGN Position: Q3 2026 in Review

Farther Finance Advisors reduced its Legend Biotech (LEGN) stake by 46% in Q3 2026, selling an estimated $7.87K and leaving 429 shares worth $8.53K. The position accounts for ﹤0.01% of the portfolio, ranked #4715.

Farther Finance Advisors first reported a position in LEGN in Q1 2024 and has held it in 11 quarters since. The position peaked at $23.2K in Q2 2026. 5 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Farther Finance Advisors held 429 shares of Legend Biotech worth $8.53K as of Q3 2026.
  • Farther Finance Advisors sold 369 Legend Biotech shares in Q3 2026, an estimated $7.87K.
  • Legend Biotech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4715 holding.
  • Farther Finance Advisors first reported a position in Legend Biotech in Q1 2024 and has held it in 11 quarters since.
  • Farther Finance Advisors's Legend Biotech position peaked at $23.2K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.